Stroke secondary prevention, a non-surgical and non-pharmacological consensus definition: results of a Delphi study.


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
23 Dec 2019
Historique:
received: 10 10 2019
accepted: 13 12 2019
entrez: 25 12 2019
pubmed: 25 12 2019
medline: 9 6 2020
Statut: epublish

Résumé

Evidence supporting lifestyle modification in vascular risk reduction is limited, drawn largely from primary prevention studies. To advance the evidence base for non-pharmacological and non-surgical stroke secondary prevention (SSP), empirical research is needed, informed by a consensus-derived definition of SSP. To date, no such definition has been published. We used Delphi methods to generate an evidence-based definition of non-pharmacological and non-surgical SSP. The 16 participants were members of INSsPiRE (International Network of Stroke Secondary Prevention Researchers), a multidisciplinary group of trialists, academics and clinicians. The Elicitation stage identified 49 key elements, grouped into 3 overarching domains: Risk factors, Education, and Theory before being subjected to iterative stages of elicitation, ranking, discussion, and anonymous voting. In the Action stage, following an experience-based engagement with key stakeholders, a consensus-derived definition, complementing current pharmacological and surgical SSP pathways, was finalised: Non-pharmacological and non-surgical stroke secondary prevention supports and improves long-term health and well-being in everyday life and reduces the risk of another stroke, by drawing from a spectrum of theoretically informed interventions and educational strategies. Interventions to self-manage modifiable lifestyle risk factors are contextualized and individualized to the capacities, needs, and personally meaningful priorities of individuals with stroke and their families.

Identifiants

pubmed: 31870411
doi: 10.1186/s13104-019-4857-0
pii: 10.1186/s13104-019-4857-0
pmc: PMC6929363
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

823

Références

Stroke. 2010 Feb;41(2):397-401
pubmed: 20075360
Int J Stroke. 2012 Apr;7(3):243-7
pubmed: 22405279
Stroke. 2008 May;39(5):1647-52
pubmed: 18322260
Cerebrovasc Dis. 2008;25(5):457-507
pubmed: 18477843
Lancet. 2010 Jul 10;376(9735):112-23
pubmed: 20561675
PLoS One. 2015 Mar 20;10(3):e0120902
pubmed: 25793643
Int J Behav Med. 2017 Feb;24(1):42-53
pubmed: 27469998
Syst Rev. 2018 Dec 13;7(1):231
pubmed: 30545406
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Eur J Prev Cardiol. 2014 Aug;21(8):1026-39
pubmed: 23478741
Stroke. 2007 Jun;38(6):1881-5
pubmed: 17431209

Auteurs

Maggie Lawrence (M)

Department of Nursing and Community Health, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, G4 0BA, UK. maggie.lawrence@gcu.ac.uk.

Eric Asaba (E)

Department of Neurobiology, Care Sciences, and Society (NVS), Division of Occupational Therapy, Karolinska Institutet, Stockholm, Sweden.

Elaine Duncan (E)

Department of Psychology, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.

Marie Elf (M)

School of Education, Health and Social Studies, Dalarna University, Falun, Sweden.
Architecture and Civil Engineering, Department of Building Design, Chalmers University of Technology, Gothenburg, Sweden.

Gunilla Eriksson (G)

Department of Neurobiology, Care Sciences, and Society (NVS), Division of Occupational Therapy, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroscience, Rehabilitation Medicine, Uppsala University, Uppsala, Sweden.

James Faulkner (J)

Department of Sport, Exercise and Health, University of Winchester, Winchester, UK.

Susanne Guidetti (S)

Department of Neurobiology, Care Sciences, and Society (NVS), Division of Occupational Therapy, Karolinska Institutet, Stockholm, Sweden.

Birgitta Johansson (B)

Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden.

Christina Kruuse (C)

Department of Neurology Stroke Unit and Neurovascular Research Unit, Herlev-Gentofte Hospital, Copenhagen, Denmark.

Danielle Lambrick (D)

School of Health Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.

Caitlin Longman (C)

Stroke Association, London, UK.

Lena von Koch (L)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Xu Wang (X)

Leeds School of Social Sciences, Leeds Beckett University, Leeds, UK.

Olive Lennon (O)

School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH